Scholars Central

Research articlePublished 1 Dec 2016

Anticoagulation with rivaroxaban after ultrasound-assisted catheter-directed thrombolysis in patients with intermediate highrisk pulmonary embolism a case series

Authors: Michael Schreinlechner, Markus Theurl, Rudolf Kirchmair, Wolfgang-Michael Franz, Peter Marschang

Interventional Cardiology

Volume 8 · Issue 6 · Pages 725–730

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: The optimal treatment for intermediate-high risk pulmonary embolism (PE) is still unclear and challenging. A new method for this entity is ultrasound-assisted catheter directed thrombolysis (USAT). The use of non-vitamin K antagonist anticoagulants (NOAC) is currently not recommended after thrombolysis. In our case series we tried to evaluate the efficacy and safety of NOAC treatment shortly after USAT. Methods and findings: We report five patients with intermediate-high risk pulmonary embolism who were successfully treated with rivaroxaban as post-procedural anticoagulation after USAT. The treatment was tolerated well with rapid clinical improvement and almost complete normalisation of right heart function (reduction of mean right to left ventricular (RV/LV) ratio from 1.22 (range 1.07-1.24) at baseline to 0.87 (range 0.76-1.07) three days after thrombolysis (p = 0.016). We observed one GUSTO moderate bleeding episode and a transient rise in creatinine in one patient, but no other adverse events. After 2.4 days (range 2-4 days), patients were switched from unfractionated heparin to rivaroxaban. Follow up-visit after three months showed normalisation of right heart function (RV/LV ratio 0.69 (range 0.65-0.81), no recurrent thrombotic events and no additional bleeding episodes. Conclusion: In our experience, USAT followed by post-procedural anticoagulation with rivaroxaban appears to be an effective treatment of intermediate-high risk pulmonary embolism.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalInterventional Cardiology
  • SubjectCardiology
  • BylineArticles whose byline prints “Michael Schreinlechner”
  • BylineArticles whose byline prints “Markus Theurl”
  • BylineArticles whose byline prints “Rudolf Kirchmair”
  • BylineArticles whose byline prints “Wolfgang-Michael Franz”
  • BylineArticles whose byline prints “Peter Marschang”